Tamoxifen Inhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients
Author:
Publisher
Informa UK Limited
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference17 articles.
1. Tamoxifen in the Treatment of Breast Cancer
2. Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA
3. Life threatening interaction between tamoxifen and warfarin.
4. Life threatening interaction between tamoxifen and warfarin.
5. Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-κB);Journal of Biomolecular Structure and Dynamics;2023-09-15
2. Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review;Journal of Personalized Medicine;2022-05-31
3. Distal gene regulation mediated by non-coding RNAs contributes to germline risk for breast and prostate cancer;2022-02-09
4. Phenytoin;Antiseizure Medication Interactions;2022
5. EXOGENOUS Sex Hormones and Sex Hormone Receptor Modulators in COVID‐19: Rationale and Clinical Pharmacology Considerations;Clinical Pharmacology & Therapeutics;2021-12-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3